Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Wascher

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based studyTanja Eder, Ramona Mayer, Uwe Langsenlehner, et al.
Atherosclerosis|January 22, 2003
Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial diseaseAlexander Gugl, Wilfried Renner, Gerald Seinost, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer riskUwe Langsenlehner, Babak Yazdani-Biuki, Tanja Eder, et al.
Cancer Letters|November 11, 2003
The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer riskPeter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Breast Cancer Research and Treatment|October 24, 2003
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer riskUwe Langsenlehner, Peter Krippl, Wilfried Renner, et al.
International Journal of Cancer|July 8, 2003
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer riskPeter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diabetes mellitus, coronary artery disease and heart disease (Update 2023)]Martin Clodi, Christoph H Saely, Friedrich Hoppichler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancerPeter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Breast Cancer Research and Treatment|April 2, 2005
Interleukin-10 promoter polymorphism is associated with decreased breast cancer riskUwe Langsenlehner, Peter Krippl, Wilfried Renner, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Diabetes mellitus, coronary artery disease und heart disease (Update 2019)]Martin Clodi, Christoph H Saely, Friedrich Hoppichler, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based studyTanja Eder, Ramona Mayer, Uwe Langsenlehner, et al.
Atherosclerosis|January 22, 2003
Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial diseaseAlexander Gugl, Wilfried Renner, Gerald Seinost, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer riskUwe Langsenlehner, Babak Yazdani-Biuki, Tanja Eder, et al.
Cancer Letters|November 11, 2003
The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer riskPeter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Breast Cancer Research and Treatment|October 24, 2003
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer riskUwe Langsenlehner, Peter Krippl, Wilfried Renner, et al.
International Journal of Cancer|July 8, 2003
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer riskPeter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diabetes mellitus, coronary artery disease and heart disease (Update 2023)]Martin Clodi, Christoph H Saely, Friedrich Hoppichler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancerPeter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Breast Cancer Research and Treatment|April 2, 2005
Interleukin-10 promoter polymorphism is associated with decreased breast cancer riskUwe Langsenlehner, Peter Krippl, Wilfried Renner, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Diabetes mellitus, coronary artery disease und heart disease (Update 2019)]Martin Clodi, Christoph H Saely, Friedrich Hoppichler, et al.
Pageof 8